Robert C. Doebele, MD, PhD (IMAGE) University of Colorado Anschutz Medical Campus Caption Robert C. Doebele, MD, PhD and colleagues use virtual clinical trial to compare crizotinib with entrectinib against ROS1+ non-small cell lung cancer Credit University of Colorado Cancer Center Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.